青岛海尔生物医疗股份有限公司关于召开2025年第三季度业绩说明会的公告

Core Points - The company will hold an investor briefing on October 31, 2025, to discuss its Q3 2025 financial results and operational performance [2][3][4] - The briefing will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [2][5] - Investors can submit questions from October 24 to October 30, 2025, and the company will address common concerns during the briefing [2][4][6] Meeting Details - The investor briefing is scheduled for October 31, 2025, from 11:00 AM to 12:00 PM [2][5] - The location for the meeting is the Shanghai Stock Exchange Roadshow Center, accessible via the website [2][5] - Participants can join the meeting online and will have the opportunity to ask questions [4][5] Contact Information - For inquiries, investors can contact the Haier Biomedical Securities Department at phone number 0532-88935566 or via email at haierbiomedical@haierbiomedical.com [6]